BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Fuji
QuintilesIMS
Citi
Chubb
McKinsey
Dow
Federal Trade Commission
Colorcon

Generated: January 17, 2018

DrugPatentWatch Database Preview

DILTZAC Drug Profile

« Back to Dashboard

When do Diltzac patents expire, and when can generic versions of Diltzac launch?

Diltzac is a drug marketed by Apotex Inc and is included in one NDA.

The generic ingredient in DILTZAC is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

US Patents and Regulatory Information for DILTZAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-001 Feb 1, 2006 AB4 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-004 Feb 1, 2006 AB4 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-002 Feb 1, 2006 AB4 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-003 Feb 1, 2006 AB4 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-005 Feb 1, 2006 AB4 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Citi
Medtronic
Baxter
Cerilliant
Cipla
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot